|
|
Volumn 31, Issue 12, 2013, Pages 1080-1082
|
|
Rational drug repositioning by medical genetics
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
DACLIZUMAB;
DROSPIRENONE;
ETANERCEPT;
FLUDROCORTISONE;
FUROSEMIDE;
PEGVISOMANT;
PERINDOPRIL;
RECOMBINANT INTERLEUKIN 2;
SOMAVERTD;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ACROMEGALY;
ALLELE;
ALZHEIMER DISEASE;
ANDROGEN INSENSITIVITY SYNDROME;
ANDROGEN THERAPY;
ASTHMA;
BARTTER SYNDROME;
CEREBRAL SALT WASTING;
CONGESTIVE HEART FAILURE;
DRUG REPOSITIONING;
EDEMA;
GAIN OF FUNCTION MUTATION;
GENETIC ASSOCIATION;
GENETIC DISORDER;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
HYPOGONADISM;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY TUBULE DISORDER;
LETTER;
LOSS OF FUNCTION MUTATION;
MEDICAL GENETICS;
MULTIINFARCT DEMENTIA;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
PROSTATE CANCER;
PSEUDOHYPOALDOSTERONISM;
RENAL TUBULAR DYSGENESIS;
RHEUMATOID ARTHRITIS;
SHORT STATURE;
DRUG THERAPY;
GENOME-WIDE ASSOCIATION STUDY;
HUMANS;
INDIVIDUALIZED MEDICINE;
|
|
EID: 84890046462
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2758 Document Type: Letter |
|
Times cited : (82)
|
|
References (14)
|
